Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2024 | May 15, 2024 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Mar. 31, 2024 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2024 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 001-41890 | |
Entity Registrant Name | BAYVIEW ACQUISITION CORP | |
Entity Central Index Key | 0001969475 | |
Entity Incorporation, State or Country Code | E9 | |
Entity Address, Address Line One | 420 Lexington Ave, Suite 2446 | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10170 | |
City Area Code | (347) | |
Local Phone Number | 627-0058 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | false | |
Entity Shell Company | true | |
Entity Common Stock, Shares Outstanding | 7,732,500 | |
Units, each Consisting of One Ordinary Share and One Right [Member] | ||
Title of 12(b) Security | Units, each consisting of one ordinary share and one right | |
Trading Symbol | BAYAU | |
Security Exchange Name | NASDAQ | |
Common Stock, Par Value $0.0001 Per Share [Member] | ||
Title of 12(b) Security | Common stock, par value $0.0001 per share | |
Trading Symbol | BAYA | |
Security Exchange Name | NASDAQ | |
Rights, each Right Entitling the Holder thereof to One-tenth of One Ordinary Share [Member] | ||
Title of 12(b) Security | Rights, each right entitling the holder thereof to one-tenth of one ordinary share | |
Trading Symbol | BAYAR | |
Security Exchange Name | NASDAQ |
Balance Sheets
Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash | $ 331,872 | $ 582,308 |
Other receivables (Note 6) | 199,677 | |
Prepaid expenses | 132,500 | 72,014 |
Total current assets | 664,049 | 654,322 |
Prepaid expenses – non-current | 13,310 | 29,677 |
Investment held in trust account | 60,861,367 | 60,107,055 |
Total Assets | 61,538,726 | 60,791,054 |
Current liabilities: | ||
Accrued offering costs and expenses | 466,055 | 303,759 |
Total Current Liabilities | 466,055 | 313,759 |
Deferred underwriting commission payable | 2,100,000 | 2,100,000 |
Total Liabilities | 2,566,055 | 2,413,759 |
Commitments and contingencies | ||
Ordinary shares subject to possible redemption (6,000,000 shares at redemption value of $10.14 and $10.02 as of March 31, 2024 and December 31, 2023, respectively) | 60,861,367 | 60,107,055 |
Shareholders’ Deficit: | ||
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding | ||
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,732,500 and 1,957,500 shares issued and outstanding (excluding 6,000,000 shares subject to possible redemption) at March 31, 2024 and December 31, 2023, respectively | 173 | 196 |
Additional paid-in capital | ||
Accumulated deficit | (1,888,869) | (1,729,956) |
Total Shareholders’ Deficit | (1,888,696) | (1,729,760) |
Total Liabilities and Shareholders’ Deficit | 61,538,726 | 60,791,054 |
Related Party [Member] | ||
Current liabilities: | ||
Due to related party | $ 10,000 |
Balance Sheets (Parenthetical)
Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Ordinary shares subject to possible redemption, shares | 6,000,000 | 6,000,000 |
Ordinary shares, redemption price per share | $ 10.14 | $ 10.02 |
Preferred stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 2,000,000 | 2,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Ordinary shares, par value | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, shares issued | 1,732,500 | 1,957,500 |
Ordinary shares, shares outstanding | 1,732,500 | 1,957,500 |
Statements of Operations (Unaud
Statements of Operations (Unaudited) - USD ($) | 2 Months Ended | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2024 | ||
Formation and operating costs | $ 3,105 | $ 158,936 | |
Loss from operations | (3,105) | (158,936) | |
Other Income: | |||
Interest and dividend earned on securities held in trust account | 754,312 | ||
Total other income | 754,312 | ||
Net income (loss) | $ (3,105) | $ 595,376 | |
Redeemable Common Stock [Member] | |||
Other Income: | |||
Weighted average ordinary shares outstanding - basic | 6,000,000 | ||
Weighted average ordinary shares outstanding - diluted | 6,000,000 | ||
Net income (loss) per share - basic | $ 0.11 | ||
Net income (loss) per share - diluted | $ 0.11 | ||
Non-redeemable Common Stock [Member] | |||
Other Income: | |||
Weighted average ordinary shares outstanding - basic | 1,500,000 | [1] | 1,799,258 |
Weighted average ordinary shares outstanding - diluted | 1,500,000 | [1] | 1,799,258 |
Net income (loss) per share - basic | $ 0 | $ (0.02) | |
Net income (loss) per share - diluted | $ 0 | $ (0.02) | |
[1]Excludes an aggregate of up to 225,000 287,500 100 |
Statements of Operations (Una_2
Statements of Operations (Unaudited) (Parenthetical) - USD ($) | 2 Months Ended | |
Dec. 14, 2023 | Mar. 31, 2023 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Shares forfeiture | 225,000 | |
Stock issued value new issues | $ 25,100 | |
Sponsor [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Stock issued shares new issues | 287,500 | |
Stock issued value new issues | $ 100 |
Statement of Changes in Shareho
Statement of Changes in Shareholders' Deficit (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total | |
Balance at Feb. 15, 2023 | |||||
Balance, shares at Feb. 15, 2023 | [1] | ||||
Net income (loss) | (3,105) | (3,105) | |||
Issuance of ordinary shares to Sponsors | $ 173 | 24,927 | 25,100 | ||
Issuance of ordinary shares to Sponsors, shares | [1] | 1,725,000 | |||
Balance at Mar. 31, 2023 | $ 173 | 24,927 | (3,105) | 21,995 | |
Balance, shares at Mar. 31, 2023 | [1] | 1,725,000 | |||
Balance at Dec. 31, 2023 | $ 196 | (1,729,956) | (1,729,760) | ||
Balance, shares at Dec. 31, 2023 | 1,957,500 | ||||
Forfeiture of ordinary shares by Sponsors | $ (23) | 23 | |||
Forfeiture of ordinary shares by Sponsors, shares | (225,000) | ||||
Subsequent measurement of ordinary shares subject to possible redemption (interest earned on trust account) | (23) | (754,289) | (754,312) | ||
Net income (loss) | 595,376 | 595,376 | |||
Balance at Mar. 31, 2024 | $ 173 | $ (1,888,869) | $ (1,888,696) | ||
Balance, shares at Mar. 31, 2024 | 1,732,500 | ||||
[1]Includes up to 225,000 287,500 100 |
Statement of Changes in Share_2
Statement of Changes in Shareholders' Deficit (Unaudited) (Parenthetical) - USD ($) | 2 Months Ended | |
Dec. 14, 2023 | Mar. 31, 2023 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Shares forfeiture | 225,000 | |
Stock issued value new issues | $ 25,100 | |
Sponsor [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Stock issued shares new issues | 287,500 | |
Stock issued value new issues | $ 100 |
Statement of Cash Flows (Unaudi
Statement of Cash Flows (Unaudited) - USD ($) | 2 Months Ended | 3 Months Ended |
Mar. 31, 2023 | Mar. 31, 2024 | |
Cash flows from operating activities: | ||
Net income (loss) | $ (3,105) | $ 595,376 |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Income earned on investments held in Trust Account | (754,312) | |
Accrued offering costs and expenses | 35,563 | |
Prepaid expenses | (87,386) | |
Due to related party | (10,000) | |
Other receivables | (29,677) | |
Formation and operating costs | 3,105 | |
Net cash used in operating activities | (250,436) | |
Net change in cash | (250,436) | |
Cash at beginning of period | 582,308 | |
Cash at end of period | 331,872 | |
Supplemental disclosure of noncash investing and financing activities | ||
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) | 754,312 | |
Deferred offering costs paid by Sponsors in exchange for issuance of ordinary shares | 25,100 | |
Deferred offering costs paid by related party | 113,305 | |
Deferred offering costs included in accrued expenses | 15,995 | |
Prepaid expenses included in due to related party | $ 1,429 |
ORGANIZATION AND BUSINESS OPERA
ORGANIZATION AND BUSINESS OPERATIONS | 3 Months Ended |
Mar. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1 — ORGANIZATION AND BUSINESS OPERATIONS Organizational and General Bayview Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 16, 2023. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company’s sponsors are Peace Investment Holdings Limited, a British Virgin Islands company, and Bayview Holding LP, a Delaware limited partnership (the “Sponsors”). As of March 31, 2024, the Company had not commenced any operations. All activities for the period from February 16, 2023 (inception) through March 31, 2024 related to the Company’s formation and the initial public offering (“IPO”), and subsequent to the IPO, identifying a target company for an initial Business Combination. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest or dividend income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on December 14, 2023. Additionally, on December 14, 2023, the Company filed a registration statement adding securities to the Registration Statement. On December 19, 2023, the Company consummated the IPO of 6,000,000 10.00 60,000,000 232,500 10.00 2,325,000 The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to 900,000 225,000 The Company will have until 9 months from the closing of the Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination as described in this prospectus) to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100 Going Concern Consideration As of March 31, 2024, the Company had cash of $ 331,872 197,994 |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. These unaudited financial statements should be read in conjunction with the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed by the Company with the SEC on April 16, 2024. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalent balance of $ 331,872 582,308 Investments Held in Trust Account The Company’s portfolio of investments held in the trust account is comprised of investments in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and Money Market Fund. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of March 31, 2024 and December 31, 2023, the Trust Account had balances of $ 60,861,367 60,107,055 754,312 Offering Costs Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on December 19, 2023. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS Three months ended For the period from February 16, 2023 (inception) March 31, 2024 through March 31, 2023 Net income (loss) $ 595,376 $ (3,105 ) Income earned on investment held in Trust Account (754,312 ) - Net loss including accretion of equity into redemption value $ (158,936 ) $ (3,105 ) SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED Redeemable Non- Redeemable Non- Redeemable Three months ended March 31, 2024 For the period from February 16, 2023 (inception) through March 31, 2023 Redeemable Non- Redeemable Redeemable Non- Redeemable Shares Shares Shares Shares Basic and diluted net income (loss) per share: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Numerators: Allocation of net loss including accretion of temporary equity $ (122,270 ) $ (36,666 ) - $ (3,105 ) Income earned on investment held in Trust Account 754,312 — - — Allocation of net income (loss) 632,042 (36,666 ) - (3,105 ) Denominators: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Basic and diluted net income (loss) per share $ 0.11 $ (0.02 ) - $ (0.00 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000 Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “ Fair Value Measurement Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds $ 60,000,000 Less: Proceeds allocated to Public Rights (2,460,000 ) Allocation of offering costs related to redeemable shares (4,163,327 ) Plus: Accretion of carrying value to redemption value 6,623,327 Ordinary shares subject to possible redemption $ 60,000,000 Plus: Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 107,055 Ordinary shares subject to possible redemption as of December 31, 2023 $ 60,107,055 Plus : Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 754,312 Ordinary shares subject to possible redemption as of March 31, 2024 60,861,367 Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 3 Months Ended |
Mar. 31, 2024 | |
Initial Public Offering | |
INITIAL PUBLIC OFFERING | NOTE 3 — INITIAL PUBLIC OFFERING On December 19, 2023, the Company sold 6,000,000 10.00 Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights. |
PRIVATE PLACEMENTS
PRIVATE PLACEMENTS | 3 Months Ended |
Mar. 31, 2024 | |
Private Placements | |
PRIVATE PLACEMENTS | NOTE 4 — PRIVATE PLACEMENTS Simultaneously with the closing of the IPO, the Company consummated the private sale of 232,500 10.00 2,325,000 Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. |
RELATED PARTIES
RELATED PARTIES | 3 Months Ended |
Mar. 31, 2024 | |
Related Party Transactions [Abstract] | |
RELATED PARTIES | NOTE 5 — RELATED PARTIES Founder Shares On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 25,000 963,125 On December 14, 2023, the Company issued 287,500 100 569,250 1,155,750 100 On January 28, 2024, a total of 225,000 Promissory Note — Related Party On February 23, 2023, the Sponsors issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $ 300,000 Due to Related Party The Sponsors paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts were due on demand and non-interest bearing, which was fully repaid upon closing of the IPO on December 19, 2023. As of March 31, 2024 and December 31, 2023, amount due to related party was 0 10,000 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 6 — COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (“UPO”), and Units that may be issued upon conversion of working capital loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day option from the date of IPO to purchase up to 900,000 225,000 The underwriter was entitled to a cash underwriting discounts of $ 0.20 1,200,000 1,380,000 1,200,000 The underwriter will be entitled to a deferred commission of $ 0.35 per Unit, or $ 2,100,000 in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the escrow trust account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement. The deferred underwriting commission was reported as non-current liability on the balance sheet dated March 31, 2024. Unit Purchase Option We have agreed to sell to Chardan and/or its designees, for $ 100 540,000 11.50 115 540,000 540,000 54,000 Business Combination Transaction Costs The Company has engaged several service providers specifically for the potential business combination. Per the agreed terms with the potential target company, the potential target company will be responsible for the expenses incurred in connection with the business combination. During the three months ended March 31, 2024, $ 170,000 170,000 |
SHAREHOLDERS_ EQUITY
SHAREHOLDERS’ EQUITY | 3 Months Ended |
Mar. 31, 2024 | |
Equity [Abstract] | |
SHAREHOLDERS’ EQUITY | NOTE 7 — SHAREHOLDERS’ EQUITY Preferred Shares 2,000,000 0.0001 voting and other rights and preferences as may be determined from time to time by the Company’s board of directors no Ordinary Shares 200,000,000 0.0001 On February 23, 2023, our sponsor, Bayview Holding LP, acquired 1,437,500 25,000 963,125 On December 14, 2023, the Company issued 287,500 100 569,250 1,155,750 100 225,000 Considered the nominal issuance, there was 1,725,00 6,000,000 225,000 As of March 31, 2024 and December 31, 2023, there were 1,732,500 1,957,500 6,000,000 Rights each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | NOTE 8 — Fair Value Measurements The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS Quoted Significant Significant Prices in Other Other As of Active Observable Unobservable March 31, Markets Inputs Inputs 2024 (Level 1) (Level 2) (Level 3) Assets: Investment held in trust account $ 60,861,367 $ 60,861,367 $ — $ — Quoted Significant Significant As of Prices in Other Other December Active Observable Unobservable 31, Markets Inputs Inputs 2023 (Level 1) (Level 2) (Level 3) Assets: Investment held in trust account $ 60,107,055 $ 60,107,055 $ — $ — |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2024 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. These unaudited financial statements should be read in conjunction with the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed by the Company with the SEC on April 16, 2024. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and cash equivalents | Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalent balance of $ 331,872 582,308 |
Investments Held in Trust Account | Investments Held in Trust Account The Company’s portfolio of investments held in the trust account is comprised of investments in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and Money Market Fund. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of March 31, 2024 and December 31, 2023, the Trust Account had balances of $ 60,861,367 60,107,055 754,312 |
Offering Costs | Offering Costs Offering costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on December 19, 2023. |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. |
Net Income (Loss) per Ordinary Share | Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS Three months ended For the period from February 16, 2023 (inception) March 31, 2024 through March 31, 2023 Net income (loss) $ 595,376 $ (3,105 ) Income earned on investment held in Trust Account (754,312 ) - Net loss including accretion of equity into redemption value $ (158,936 ) $ (3,105 ) SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED Redeemable Non- Redeemable Non- Redeemable Three months ended March 31, 2024 For the period from February 16, 2023 (inception) through March 31, 2023 Redeemable Non- Redeemable Redeemable Non- Redeemable Shares Shares Shares Shares Basic and diluted net income (loss) per share: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Numerators: Allocation of net loss including accretion of temporary equity $ (122,270 ) $ (36,666 ) - $ (3,105 ) Income earned on investment held in Trust Account 754,312 — - — Allocation of net income (loss) 632,042 (36,666 ) - (3,105 ) Denominators: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Basic and diluted net income (loss) per share $ 0.11 $ (0.02 ) - $ (0.00 ) |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000 |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “ Fair Value Measurement |
Ordinary Shares Subject to Possible Redemption | Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds $ 60,000,000 Less: Proceeds allocated to Public Rights (2,460,000 ) Allocation of offering costs related to redeemable shares (4,163,327 ) Plus: Accretion of carrying value to redemption value 6,623,327 Ordinary shares subject to possible redemption $ 60,000,000 Plus: Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 107,055 Ordinary shares subject to possible redemption as of December 31, 2023 $ 60,107,055 Plus : Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 754,312 Ordinary shares subject to possible redemption as of March 31, 2024 60,861,367 |
Recent Accounting Standards | Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS | The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS Three months ended For the period from February 16, 2023 (inception) March 31, 2024 through March 31, 2023 Net income (loss) $ 595,376 $ (3,105 ) Income earned on investment held in Trust Account (754,312 ) - Net loss including accretion of equity into redemption value $ (158,936 ) $ (3,105 ) |
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED | SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED Redeemable Non- Redeemable Non- Redeemable Three months ended March 31, 2024 For the period from February 16, 2023 (inception) through March 31, 2023 Redeemable Non- Redeemable Redeemable Non- Redeemable Shares Shares Shares Shares Basic and diluted net income (loss) per share: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Numerators: Allocation of net loss including accretion of temporary equity $ (122,270 ) $ (36,666 ) - $ (3,105 ) Income earned on investment held in Trust Account 754,312 — - — Allocation of net income (loss) 632,042 (36,666 ) - (3,105 ) Denominators: Weighted-average shares outstanding 6,000,000 1,799,258 - 1,500,000 Basic and diluted net income (loss) per share $ 0.11 $ (0.02 ) - $ (0.00 ) |
SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET | At March 31, 2024, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET Public offering proceeds $ 60,000,000 Less: Proceeds allocated to Public Rights (2,460,000 ) Allocation of offering costs related to redeemable shares (4,163,327 ) Plus: Accretion of carrying value to redemption value 6,623,327 Ordinary shares subject to possible redemption $ 60,000,000 Plus: Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 107,055 Ordinary shares subject to possible redemption as of December 31, 2023 $ 60,107,055 Plus : Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) 754,312 Ordinary shares subject to possible redemption as of March 31, 2024 60,861,367 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS | The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS Quoted Significant Significant Prices in Other Other As of Active Observable Unobservable March 31, Markets Inputs Inputs 2024 (Level 1) (Level 2) (Level 3) Assets: Investment held in trust account $ 60,861,367 $ 60,861,367 $ — $ — Quoted Significant Significant As of Prices in Other Other December Active Observable Unobservable 31, Markets Inputs Inputs 2023 (Level 1) (Level 2) (Level 3) Assets: Investment held in trust account $ 60,107,055 $ 60,107,055 $ — $ — |
ORGANIZATION AND BUSINESS OPE_2
ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($) | 2 Months Ended | 3 Months Ended | |||
Jan. 28, 2024 | Dec. 19, 2023 | Mar. 31, 2023 | Mar. 31, 2024 | Dec. 31, 2023 | |
Subsidiary, Sale of Stock [Line Items] | |||||
Number of shares forfeited by sponsors | 225,000 | ||||
Percentage of outstanding voting securities | 100% | ||||
Cash | $ 331,872 | $ 582,308 | |||
Working capital | $ 197,994 | ||||
IPO [Member] | |||||
Subsidiary, Sale of Stock [Line Items] | |||||
Number of share units issued | 6,000,000 | ||||
Share price | $ 10 | ||||
Proceeds from initial public offering | $ 60,000,000 | ||||
Private Placement [Member] | |||||
Subsidiary, Sale of Stock [Line Items] | |||||
Number of share units issued | 232,500 | ||||
Share price | $ 10 | ||||
Proceeds from private placement | $ 2,325,000 | ||||
Over-Allotment Option [Member] | |||||
Subsidiary, Sale of Stock [Line Items] | |||||
Stock issued during the period, shares | 900,000 | ||||
Number of shares forfeited by sponsors | 225,000 |
SCHEDULE OF NET INCOME (LOSS) P
SCHEDULE OF NET INCOME (LOSS) PER SHARE PRESENTED STATEMENTS OF OPERATIONS (Details) - USD ($) | 2 Months Ended | 3 Months Ended |
Mar. 31, 2023 | Mar. 31, 2024 | |
Accounting Policies [Abstract] | ||
Net income (loss) | $ (3,105) | $ 595,376 |
Income earned on investment held in Trust Account | (754,312) | |
Net loss including accretion of equity into redemption value | $ (3,105) | $ (158,936) |
SCHEDULE OF EARNINGS PER SHARE
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($) | 2 Months Ended | 3 Months Ended |
Mar. 31, 2023 | Mar. 31, 2024 | |
Income earned on investment held in Trust Account | $ 754,312 | |
Redeemable Shares [Member] | ||
Weighted average shares outstanding - basic | 6,000,000 | |
Weighted average shares outstanding - diluted | 6,000,000 | |
Basic net income/(loss) per share | $ 0.11 | |
Diluted net income/(loss) per share | $ 0.11 | |
Non-redeemable Shares [Member] | ||
Weighted average shares outstanding - basic | 1,500,000 | 1,799,258 |
Weighted average shares outstanding - diluted | 1,500,000 | 1,799,258 |
Basic net income/(loss) per share | $ 0 | $ (0.02) |
Diluted net income/(loss) per share | $ 0 | $ (0.02) |
Redeemable Shares [Member] | ||
Weighted average shares outstanding - basic | 6,000,000 | |
Weighted average shares outstanding - diluted | 6,000,000 | |
Allocation of net loss including accretion of temporary equity | $ (122,270) | |
Income earned on investment held in Trust Account | 754,312 | |
Allocation of net income (loss) | $ 632,042 | |
Non-redeemable Shares [Member] | ||
Weighted average shares outstanding - basic | 1,500,000 | 1,799,258 |
Weighted average shares outstanding - diluted | 1,500,000 | 1,799,258 |
Allocation of net loss including accretion of temporary equity | $ (3,105) | $ (36,666) |
Income earned on investment held in Trust Account | ||
Allocation of net income (loss) | $ (3,105) | $ (36,666) |
SCHEDULE OF ORDINARY SHARES SUB
SCHEDULE OF ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION REFLECTED IN THE BALANCE SHEET (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | |
Accounting Policies [Abstract] | |||
Public offering proceeds | $ 60,000,000 | ||
Proceeds allocated to public rights | (2,460,000) | ||
Allocation of offering costs related to redeemable shares | (4,163,327) | ||
Accretion of carrying value to redemption value | 6,623,327 | ||
Ordinary shares subject to possible redemption | $ 60,107,055 | $ 60,000,000 | |
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) | 754,312 | 107,055 | |
Ordinary shares subject to possible redemption | $ 60,861,367 | $ 60,107,055 | $ 60,000,000 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 2 Months Ended | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2024 | Dec. 31, 2023 | |
Accounting Policies [Abstract] | |||
Cash and cash equivalents | $ 331,872 | $ 582,308 | |
Cash held in Trust Account | 60,861,367 | 60,107,055 | |
Interest and dividend earned on marketable securities held in trust account | 754,312 | ||
Unrecognized tax benefits | $ 0 | ||
Cash, FDIC insured amount | $ 250,000 |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Details Narrative) - IPO [Member] | Dec. 19, 2023 $ / shares shares |
Subsidiary, Sale of Stock [Line Items] | |
Stock issued shares new issues | shares | 6,000,000 |
Sale of stock, par share | $ / shares | $ 10 |
Stock holders equity related to initial public offering description | Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. Ten Public Rights will entitle the holder to one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade, so unless a holder purchased units in multiples of tens, such holder will not be able to receive or trade the fractional shares underlying the rights. |
PRIVATE PLACEMENTS (Details Nar
PRIVATE PLACEMENTS (Details Narrative) - Private Placement [Member] | Dec. 19, 2023 USD ($) $ / shares shares |
Subsidiary, Sale of Stock [Line Items] | |
Stock issued shares new issues | shares | 232,500 |
Share price | $ / shares | $ 10 |
Proceeds from private placement | $ | $ 2,325,000 |
Stock holders equity related to private placement description | Each Private Placement Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination. |
RELATED PARTIES (Details Narrat
RELATED PARTIES (Details Narrative) - USD ($) | 2 Months Ended | |||||||
Jan. 28, 2024 | Dec. 27, 2023 | Dec. 14, 2023 | Mar. 14, 2023 | Feb. 23, 2023 | Mar. 31, 2023 | Mar. 31, 2024 | Dec. 31, 2023 | |
Related Party Transaction [Line Items] | ||||||||
Proceeds from issuance of common stock | $ 25,100 | |||||||
Number of shares forfeited by sponsors | 225,000 | |||||||
Over-Allotment Option [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Number of shares forfeited by sponsors | 225,000 | |||||||
Related Party [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Due to related party | $ 10,000 | |||||||
Related Party [Member] | Promissory Note [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Promissory note aggregate principal amount | $ 300,000 | |||||||
Founder Shares [Member] | Investor [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Proceeds from Issuance of Common Stock | $ 100 | |||||||
Founder Shares [Member] | Bayview Holding LP [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued shares new issues | 569,250 | |||||||
Founder Shares [Member] | Peace Investment Holdings Limited [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued shares new issues | 1,155,750 | |||||||
Sponsors [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued shares new issues | 963,125 | 1,437,500 | ||||||
Proceeds from issuance of common stock | $ 25,000 | |||||||
Payments to related party | $ 100 | |||||||
Sponsors [Member] | Founder Shares [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued shares new issues | 287,500 | 963,125 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) | 2 Months Ended | 3 Months Ended | ||
Jan. 28, 2024 | Dec. 19, 2023 | Mar. 31, 2023 | Mar. 31, 2024 | |
Subsidiary, Sale of Stock [Line Items] | ||||
Number of shares forfeited by sponsors | 225,000 | |||
Cash underwriting discount per unit | $ 0.20 | |||
Cash underwriting discount | $ 1,200,000 | |||
Deferred commission per unit | $ 0.35 | |||
Deferred commission | $ 2,100,000 | |||
Proceeds from stock options exercised | $ 100 | |||
Shares exercisable | 540,000 | |||
Exercise price | $ 11.50 | |||
Exercise price percentage | 115% | |||
Number of options and units, shares | 540,000 | |||
Number of options and units, ordinary shares | 540,000 | |||
Number of options and units, rights to purchas ordinary shares | 54,000 | |||
Business combination related cost | $ 170,000 | |||
Business combination contingent consideration , receivables | $ 170,000 | |||
Over-Allotment Option [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Stock issued during the period, shares | 900,000 | |||
Number of shares forfeited by sponsors | 225,000 | |||
Stock issued during the period, value | $ 1,380,000 |
SHAREHOLDERS_ EQUITY (Details N
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($) | 2 Months Ended | 3 Months Ended | |||||||
Jan. 28, 2024 | Dec. 27, 2023 | Dec. 14, 2023 | Mar. 31, 2023 | Mar. 14, 2023 | Feb. 23, 2023 | Mar. 31, 2023 | Mar. 31, 2024 | Dec. 31, 2023 | |
Class of Stock [Line Items] | |||||||||
Preferred stock, shares authorized | 2,000,000 | 2,000,000 | |||||||
Preferred stock, par value | $ 0.0001 | $ 0.0001 | |||||||
Preferred stock voting rights | voting and other rights and preferences as may be determined from time to time by the Company’s board of directors | ||||||||
Preferred stock, shares issued | 0 | 0 | |||||||
Preferred stock, shares outstanding | 0 | 0 | |||||||
Ordinary stock, shares authorized | 200,000,000 | 200,000,000 | |||||||
Ordinary stock, par value | $ 0.0001 | $ 0.0001 | |||||||
Stock issued value new issues | $ 25,100 | ||||||||
Number of shares forfeited by sponsors | 225,000 | ||||||||
Common stock, shares issued | 1,725 | 1,725 | 1,732,500 | 1,957,500 | |||||
Common stock, shares outstanding | 1,725 | 1,725 | 1,732,500 | 1,957,500 | |||||
Shares subject to possible redemption, shares | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | |||||
Rights description | each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination. | ||||||||
Over-Allotment Option [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Number of shares forfeited by sponsors | 225,000 | ||||||||
Founder Shares [Member] | Investor [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Proceeds from Issuance of Common Stock | $ 100 | ||||||||
Founder Shares [Member] | Bayview Holding LP [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Stock issued shares new issues | 569,250 | ||||||||
Founder Shares [Member] | Peace Investment Holdings Limited [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Stock issued shares new issues | 1,155,750 | ||||||||
Sponsors [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Stock issued shares new issues | 963,125 | 1,437,500 | |||||||
Stock issued value new issues | $ 25,000 | ||||||||
Payments to related party | $ 100 | ||||||||
Ordinary shares subject to forfeiture | 225,000 | ||||||||
Sponsors [Member] | Founder Shares [Member] | |||||||||
Class of Stock [Line Items] | |||||||||
Stock issued shares new issues | 287,500 | 963,125 |
SCHEDULE OF MEASURED FAIR VALUE
SCHEDULE OF MEASURED FAIR VALUE ON RECURRING BASIS (Details) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Investment held in trust account | $ 60,861,367 | $ 60,107,055 |
Fair Value, Inputs, Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Investment held in trust account | 60,861,367 | 60,107,055 |
Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Investment held in trust account | ||
Fair Value, Inputs, Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Investment held in trust account |